hydroxychloroquine has been researched along with Latent Tuberculosis in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Latent Tuberculosis: The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alemu, A | 3 |
| Bitew, ZW | 3 |
| Seid, G | 3 |
| Diriba, G | 3 |
| Gashu, E | 3 |
| Berhe, N | 3 |
| Mariam, SH | 3 |
| Gumi, B | 3 |
| Xu, Q | 1 |
| Gu, Y | 1 |
| Li, Y | 1 |
| Ling, B | 1 |
| Yu, H | 1 |
| Yao, Z | 1 |
| Gaffney, RG | 1 |
| Werth, VP | 1 |
| Heymann, WR | 1 |
1 review available for hydroxychloroquine and Latent Tuberculosis
| Article | Year |
|---|---|
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberc | 2022 |
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberc | 2022 |
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberc | 2022 |
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberc | 2022 |
3 other studies available for hydroxychloroquine and Latent Tuberculosis
| Article | Year |
|---|---|
Concurrence of generalized perforating and subcutaneous granuloma annulare in a 4-year-old boy with latent tuberculosis infection successfully treated with low-dose hydroxychloroquine.
Topics: Biopsy; Child, Preschool; Drug Administration Schedule; Enzyme-Linked Immunospot Assay; Granuloma An | 2020 |
Evaluating results of an interferon-γ release assay in patients with autoimmune disease who are taking hydroxychloroquine.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Dermatomyositis; Female; Humans; Hydrox | 2019 |
The hydroxychloroquine-interferon gamma release assay question: TB or not TB?
Topics: Dermatologic Agents; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppressive Agents; I | 2019 |